BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36688363)

  • 1. Is the long-acting gonadotropin-releasing hormone agonist long protocol better for patients with endometriosis undergoing IVF?
    Wang X; Li W; Chen X; Zhang W; Chu M; Yin S; Chu Y; Liu X
    Int J Gynaecol Obstet; 2023 Jul; 162(1):325-332. PubMed ID: 36688363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of the long-acting gonadotropin-releasing hormone agonist long protocol on IVF/ICSI outcomes of patients with repeated implantation failure.
    Chen X; Zhang W; Xu Y; Li W; Wang X; Shi S; Liu X
    Int J Gynaecol Obstet; 2024 Feb; 164(2):563-570. PubMed ID: 37792887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The depot GnRH agonist protocol improves the live birth rate per fresh embryo transfer cycle, but not the cumulative live birth rate in normal responders: a randomized controlled trial and molecular mechanism study.
    Xu B; Geerts D; Hu S; Yue J; Li Z; Zhu G; Jin L
    Hum Reprod; 2020 Jun; 35(6):1306-1318. PubMed ID: 32478400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovulation triggering with hCG alone, GnRH agonist alone or in combination? A randomized controlled trial in advanced-age women undergoing IVF/ICSI cycles.
    Zhou C; Yang X; Wang Y; Xi J; Pan H; Wang M; Zhou Y; Xiao Y
    Hum Reprod; 2022 Jul; 37(8):1795-1805. PubMed ID: 35595223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The comparison of two different protocols ultra-long versus medroxyprogesterone acetate in women with ovarian endometriosis: a prospective randomized controlled trial.
    Guo H; Du T; Gao H; Xi Q; Wu L; Lyu Q; Zhu Q
    Reprod Health; 2022 Oct; 19(1):198. PubMed ID: 36195878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GnRHa flare and IVF pregnancy rates.
    Confino E; Zhang X; Kazer RR
    Int J Gynaecol Obstet; 2004 Apr; 85(1):36-9. PubMed ID: 15050465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depot versus daily administration of gonadotrophin-releasing hormone agonist protocols for pituitary down regulation in assisted reproduction cycles.
    Albuquerque LE; Tso LO; Saconato H; Albuquerque MC; Macedo CR
    Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD002808. PubMed ID: 23440788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GnRH agonist versus HCG triggering in different IVF/ICSI cycles of same patients: a retrospective study.
    Yılmaz N; Ceran MU; Ugurlu EN; Gülerman HC; Engin Ustun Y
    J Obstet Gynaecol; 2020 Aug; 40(6):837-842. PubMed ID: 31791167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel strategy of using corifollitropin alfa in the ultrashort gonadotropin-releasing hormone agonist (GnRHa) protocol in unselected patients: A patient-friendly alternative.
    Yu TN; Liu YL; Wang PH; Chen CH; Chen CH; Tzeng CR
    Taiwan J Obstet Gynecol; 2019 Sep; 58(5):656-661. PubMed ID: 31542088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot study to search possible mechanisms of ultralong gonadotropin-releasing hormone agonist therapy in IVF-ET patients with endometriosis.
    Tamura H; Takasaki A; Nakamura Y; Numa F; Sugino N
    J Ovarian Res; 2014 Oct; 7():100. PubMed ID: 25331066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes.
    Weitzman VN; Engmann L; DiLuigi A; Maier D; Nulsen J; Benadiva C
    Fertil Steril; 2009 Jul; 92(1):226-30. PubMed ID: 18675961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fertility outcomes in women after controlled ovarian stimulation with gonadotropin releasing hormone agonist long protocol: fresh versus frozen embryo transfer.
    Ding X; Yang J; Li L; Yang N; Lan L; Huang G; Ye H
    BMC Pregnancy Childbirth; 2021 Mar; 21(1):207. PubMed ID: 33711956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depot versus daily administration of gonadotrophin releasing hormone agonist protocols for pituitary desensitization in assisted reproduction cycles.
    Albuquerque LE; Saconato H; Maciel MC
    Cochrane Database Syst Rev; 2005 Jan; (1):CD002808. PubMed ID: 15674898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of pregnancy outcomes between GnRH antagonist protocol with freeze-all strategy and long-acting GnRH agonist protocol in women with adenomyosis undergoing IVF/ICSI: a propensity-score matching analysis.
    Zhang L; Cai H; Liu X; Xiong Y; Liang X; Shi J
    BMC Pregnancy Childbirth; 2022 Dec; 22(1):946. PubMed ID: 36528566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled ovarian stimulation for endometriosis patients with ultra-long GnRH-agonist or GnRH-antagonist protocols: A retrospective study by propensity score matching.
    Chen Q; Du S; Lin Y; Zheng B
    J Obstet Gynaecol Res; 2023 May; 49(5):1366-1374. PubMed ID: 36780873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual trigger with the combination of gonadotropin-releasing hormone agonist and standard dose of human chorionic gonadotropin improves
    Mutlu I; Demirdag E; Cevher F; Erdem A; Erdem M
    J Obstet Gynaecol; 2022 Jul; 42(5):1239-1244. PubMed ID: 34565274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depot versus daily administration of gonadotrophin releasing hormone agonist protocols for pituitary desensitization in assisted reproduction cycles.
    Albuquerque LE; Saconato H; Maciel MC
    Cochrane Database Syst Rev; 2002; (3):CD002808. PubMed ID: 12137658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progestin-Primed Ovarian Stimulation Protocol for Patients With Endometrioma.
    Yang AM; Feng TF; Han Y; Zhao ZM; Wang W; Wang YZ; Zuo XQ; Xu X; Shi BJ; Li L; Hao GM; Cui N
    Front Endocrinol (Lausanne); 2022; 13():798434. PubMed ID: 35574014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of Different Gonadotropin-releasing Hormone Agonist Administration Methods on Pregnancy Outcomes of Patients Undergoing In-vitro Fertilization-embryo Transfer.
    Wu L; Ren XL; Chen W; Huang B; Zhou YF; Jin L
    Curr Med Sci; 2019 Jun; 39(3):437-441. PubMed ID: 31209816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of clinical efficacy of long- versus short-acting gonadotrophin-releasing hormone agonists for pituitary down regulation in
    Umemmuo MU; Efetie ER; Agboghoroma CO; Momoh JA; Ikechebelu JI
    Niger Postgrad Med J; 2020; 27(3):171-176. PubMed ID: 32687115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.